Sofosbuvir modulates the intimate relationship between hepatitis C virus and lipids

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|3|744-747

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.3, 2015-03, pp. : 744-747

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 823-830

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is there a straightforward relationship between hepatitis C virus infection and diabetes?

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 1097-1098

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relationship between vitamin D status and response to hepatitis C virus therapy

By  

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1642-1643

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ledipasvir‐sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1793-1797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus–coinfected liver transplant recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 2, 2015-02 ,pp. : 272-274

John Wiley & Sons Inc

Access to resources Recommend Favorite